<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Axonics Modulation Technologies, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Axonics Modulation Technologies, Inc.

    Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) is a medical technology company focused on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (“SNM”) solutions. SNM therapy is primarily used to treat patients with overactive bladder (“OAB”), fecal incontinence (“FI”) and urinary retention (“UR”). Axonics currently has marketing approvals in Europe, Canada, and Australia for OAB, FI, and UR. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $400,000,000
    • SIC CODE
      3841
    • NIN CODE
      ####
    • LEADERSHIP
      Raymond W. Cohen
    • FOUNDED
      2012
    • EMPLOYEES
      51-100
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Veracyte, Inc.

    Veracyte, Inc.

    Veracyte is a leading genomic diagnostics company that is fundamentally improving ...

    Veracyte is a leading genomic diagnostics compa...

    Filing Type:    PU
    Orthogonal Thinker Inc.

    Orthogonal Thinker Inc.

    Orthogonal is a Socially Conscious Holding Company. As such, we only invest in co...

    Orthogonal is a Socially Conscious Holding Comp...

    Amount Raised:    $522,898.00
    Fundraising Status:    EC
    Filing Type:    CF
    ChemoCentryx, Inc.

    ChemoCentryx, Inc.

    ChemoCentryx is a biopharmaceutical company focused exclusively on discovering, de...

    ChemoCentryx is a biopharmaceutical company foc...

    Filing Type:    PU
    Intellia Therapeutics, Inc.

    Intellia Therapeutics, Inc.

    Intellia Therapeutics is a leading genome editing company focused on developing cu...

    Intellia Therapeutics is a leading genome editi...

    Filing Type:    PU
    CytoDyn Inc.

    CytoDyn Inc.

    CytoDyn is a publicly traded late stage biotechnology company developing innovativ...

    CytoDyn is a publicly traded late stage biotech...

    Filing Type:    PU
    Pacific Biosciences of California, Inc.

    Pacific Biosciences of California, Inc.

    Pacific Biosciences' mission is to transform the way humankind acquires, processes...

    Pacific Biosciences' mission is to transform th...

    Filing Type:    PU
    Lantheus Holdings, Inc.

    Lantheus Holdings, Inc.

    Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc. (â...

    Lantheus Holdings, Inc. is the parent company o...

    Filing Type:    PU
    Check-Cap Ltd.

    Check-Cap Ltd.

    Check-Cap is a clinical-stage medical diagnostics company developing C-ScanÂŽ, the...

    Check-Cap is a clinical-stage medical diagnosti...

    Filing Type:    PU
    Intersect ENT, Inc.

    Intersect ENT, Inc.

    Intersect ENT (NASDAQ: XENT) is a medical technology company dedicated to advancin...

    Intersect ENT (NASDAQ: XENT) is a medical techn...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.